IL158691A0 - Solid orally-dispersible pharmaceutical formulation - Google Patents

Solid orally-dispersible pharmaceutical formulation

Info

Publication number
IL158691A0
IL158691A0 IL15869102A IL15869102A IL158691A0 IL 158691 A0 IL158691 A0 IL 158691A0 IL 15869102 A IL15869102 A IL 15869102A IL 15869102 A IL15869102 A IL 15869102A IL 158691 A0 IL158691 A0 IL 158691A0
Authority
IL
Israel
Prior art keywords
pharmaceutical formulation
solid orally
dispersible pharmaceutical
dispersible
orally
Prior art date
Application number
IL15869102A
Other languages
English (en)
Original Assignee
Roquette Freres
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roquette Freres filed Critical Roquette Freres
Publication of IL158691A0 publication Critical patent/IL158691A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Nutrition Science (AREA)
  • Zoology (AREA)
  • Physiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Rheumatology (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IL15869102A 2002-01-18 2002-12-19 Solid orally-dispersible pharmaceutical formulation IL158691A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0200647A FR2834889B1 (fr) 2002-01-18 2002-01-18 Forme pharmaceutique solide orodispersible
PCT/FR2002/004454 WO2003061623A1 (fr) 2002-01-18 2002-12-19 Forme pharmaceutique solide orodispersible

Publications (1)

Publication Number Publication Date
IL158691A0 true IL158691A0 (en) 2004-05-12

Family

ID=27589521

Family Applications (2)

Application Number Title Priority Date Filing Date
IL15869102A IL158691A0 (en) 2002-01-18 2002-12-19 Solid orally-dispersible pharmaceutical formulation
IL158691A IL158691A (en) 2002-01-18 2003-10-30 Solid pharmaceutical compositions that are dispersed in the mouth

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL158691A IL158691A (en) 2002-01-18 2003-10-30 Solid pharmaceutical compositions that are dispersed in the mouth

Country Status (22)

Country Link
US (1) US7201922B2 (cs)
EP (1) EP1465593B1 (cs)
JP (1) JP2005515240A (cs)
KR (1) KR100961367B1 (cs)
CN (1) CN1248681C (cs)
AT (1) ATE439828T1 (cs)
AU (1) AU2002364468C1 (cs)
BR (1) BR0208161A (cs)
CA (1) CA2441796A1 (cs)
CZ (1) CZ20032486A3 (cs)
DE (1) DE60233436D1 (cs)
FR (1) FR2834889B1 (cs)
HU (1) HUP0303948A2 (cs)
IL (2) IL158691A0 (cs)
MX (1) MXPA03008420A (cs)
NO (1) NO326259B1 (cs)
NZ (1) NZ529694A (cs)
PL (1) PL209144B1 (cs)
RU (1) RU2317812C2 (cs)
SK (1) SK287812B6 (cs)
WO (1) WO2003061623A1 (cs)
ZA (1) ZA200308664B (cs)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7815937B2 (en) * 1998-10-27 2010-10-19 Biovail Laboratories International Srl Quick dissolve compositions and tablets based thereon
AU1323400A (en) * 1998-10-27 2000-05-15 Fuisz Technologies Ltd. Microparticles containing peg and/or peg glyceryl esters
FR2834894B1 (fr) * 2002-01-21 2004-02-27 Servier Lab Composition pharmaceutique orodispersible de piribedil
FR2834896B1 (fr) * 2002-01-23 2004-02-27 Servier Lab Composition pharmaceutique orodispersible d'ivabradine
FR2834890B1 (fr) * 2002-01-23 2004-02-27 Servier Lab Composition pharmaceutique orodispersible d'agomelatine
FR2834893B1 (fr) * 2002-01-23 2004-02-27 Servier Lab Composition pharmaceutique orodispersible de perindopril
DE10229472A1 (de) * 2002-07-01 2004-01-15 Symrise Gmbh & Co. Kg Kompaktierter Milchsäurementhylester
FR2857263B1 (fr) * 2003-07-09 2005-09-09 Sanofi Synthelabo Nouvelle composition pharmaceutique solide comprenant de l'amisulpride
FR2858556B1 (fr) * 2003-08-06 2006-03-10 Galenix Innovations Composition pharmaceutique solide dispersible et/ou orodispersible non pelliculee contenant au moins le principe actif metformine, et procede de preparation
TWI347942B (en) * 2005-06-22 2011-09-01 Lundbeck & Co As H Crystalline base of escitalopram and orodispersible tablets comprising escitalopram base
KR101109633B1 (ko) 2007-08-03 2012-01-31 제이더블유중외제약 주식회사 활성성분의 코팅막이 보호되는 구강내붕해제형을 제조하기위한 조성물
FR2920311B1 (fr) * 2007-08-31 2010-06-18 Galenix Innovations Composition solide, orodispersible et/ou dispersible, sans excipient a effet notoire et son procede de preparation
ES2758624T3 (es) * 2009-02-12 2020-05-06 Fuji Chem Ind Co Ltd Composición de partículas desintegrantes y material de desintegración rápida moldeado por compresión que comprende la misma
RU2497505C1 (ru) * 2012-11-07 2013-11-10 Максим Эдуардович Запольский Новая лекарственная композиция для лечения болевого синдрома при спазме гладкой мускулатуры
RU2503447C1 (ru) * 2012-11-20 2014-01-10 Максим Эдуардович Запольский Лекарственное средство в форме ородисперсной таблетки и способ получения лекарственного средства
WO2015008825A1 (ja) * 2013-07-19 2015-01-22 株式会社三和化学研究所 口腔内崩壊錠
DE102017103346A1 (de) 2017-02-17 2018-08-23 Lts Lohmann Therapie-Systeme Ag Strukturierte orodispergierbare Filme
WO2019146642A1 (ja) * 2018-01-24 2019-08-01 大原薬品工業株式会社 γ－アミノ酪酸誘導体含有錠剤の化学的安定性を改善する方法
MX2023008370A (es) * 2023-07-13 2025-02-10 Posi Visionary Solutions Llp Composicion farmaceutica orodispersable de clonazepam

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4327077A (en) * 1981-05-29 1982-04-27 Life Savers, Inc. Compressed chewable antacid tablet and method for forming same
US5464632C1 (en) 1991-07-22 2001-02-20 Prographarm Lab Rapidly disintegratable multiparticular tablet
JP3349535B2 (ja) * 1993-01-12 2002-11-25 フロイント産業株式会社 球形顆粒の製造方法
US5895664A (en) * 1993-09-10 1999-04-20 Fuisz Technologies Ltd. Process for forming quickly dispersing comestible unit and product therefrom
IL112106A0 (en) * 1993-12-22 1995-03-15 Ergo Science Inc Accelerated release composition containing bromocriptine
ES2082723B1 (es) * 1994-07-20 1996-10-01 Lilly Sa Formulacion farmaceutica de fluoxetina en forma dispersable.
JP4064476B2 (ja) * 1996-03-29 2008-03-19 エラワン ファーマスーティカル リサーチ アンドラボラトリー カンパニー リミテッド 二酸化珪素を有する球状凝集した澱粉
DE69732909T2 (de) * 1996-07-12 2005-08-11 Daiichi Pharmaceutical Co., Ltd. Rasch zerfallende Pressmasse und Verfahren zu ihrer Herstellung
FR2752162B1 (fr) 1996-08-07 1998-11-06 Jouveinal Lab Comprime de maleate de trimebutine pellicule
FR2766089B1 (fr) 1997-07-21 2000-06-02 Prographarm Lab Comprime multiparticulaire perfectionne a delitement rapide
GB9901819D0 (en) * 1999-01-27 1999-03-17 Scherer Corp R P Pharmaceutical compositions
WO2000057857A1 (en) 1999-03-25 2000-10-05 Yuhan Corporation Rapidly disintegrable tablet for oral administration
US6316029B1 (en) * 2000-05-18 2001-11-13 Flak Pharma International, Ltd. Rapidly disintegrating solid oral dosage form
DE60036205T2 (de) * 2000-07-27 2008-05-21 Roquette Frères Granulat bestehend aus Stärke und Laktose
CN1469737A (zh) * 2000-10-16 2004-01-21 ��һ��������ҩ��ʽ���� 口腔内快速崩解的药用组合物及其制备方法
FR2823668B1 (fr) * 2001-04-20 2004-02-27 Ethypharm Lab Prod Ethiques Comprimes effervescents orodispersibles
US6723348B2 (en) * 2001-11-16 2004-04-20 Ethypharm Orodispersible tablets containing fexofenadine
US7118765B2 (en) * 2001-12-17 2006-10-10 Spi Pharma, Inc. Co-processed carbohydrate system as a quick-dissolve matrix for solid dosage forms
IL161996A0 (en) * 2001-12-21 2005-11-20 Pfizer Prod Inc Directly compressible formulations of azithromycin
FR2834890B1 (fr) * 2002-01-23 2004-02-27 Servier Lab Composition pharmaceutique orodispersible d'agomelatine
EP1487419A2 (en) * 2002-03-20 2004-12-22 Elan Pharma International Limited Fast dissolving dosage forms having reduced friability

Also Published As

Publication number Publication date
CN1516576A (zh) 2004-07-28
US20030147947A1 (en) 2003-08-07
JP2005515240A (ja) 2005-05-26
FR2834889A1 (fr) 2003-07-25
FR2834889B1 (fr) 2004-04-02
SK11712003A3 (sk) 2004-02-03
ZA200308664B (en) 2004-11-08
IL158691A (en) 2008-08-07
NO20034139D0 (no) 2003-09-17
MXPA03008420A (es) 2004-03-16
DE60233436D1 (de) 2009-10-01
CZ20032486A3 (cs) 2004-01-14
ATE439828T1 (de) 2009-09-15
BR0208161A (pt) 2004-03-02
AU2002364468B2 (en) 2008-06-26
KR20040073288A (ko) 2004-08-19
KR100961367B1 (ko) 2010-06-07
RU2317812C2 (ru) 2008-02-27
EP1465593A1 (fr) 2004-10-13
PL362762A1 (en) 2004-11-02
NO20034139L (no) 2003-11-11
CN1248681C (zh) 2006-04-05
HU0303948D0 (en) 2004-01-28
PL209144B1 (pl) 2011-07-29
SK287812B6 (sk) 2011-10-04
HUP0303948A2 (hu) 2004-04-28
RU2003128025A (ru) 2005-03-27
AU2002364468C1 (en) 2009-01-22
CA2441796A1 (fr) 2003-07-31
WO2003061623A1 (fr) 2003-07-31
EP1465593B1 (fr) 2009-08-19
NO326259B1 (no) 2008-10-27
NZ529694A (en) 2006-04-28
US7201922B2 (en) 2007-04-10

Similar Documents

Publication Publication Date Title
HU0303948D0 (en) Solid orally-dispersible pharmaceutical formulation
TW200626526A (en) Pharmaceutical compositions for the treatment of neoplasms
IL174863A0 (en) Compounds that inhibit serine proteases and pharmaceutical compositions containing the same
MXPA04008772A (es) Composiciones de clorhidrato de naltrexona.
DE60029956D1 (de) Amid-substituierte Imidazochinoline
IL171285A (en) Pharmaceuticals containing interleukin-6 antagonist and their uses
IL170454A (en) Preparations of active ingredients for administration through the skin or through mucous membranes and their uses
TW200514784A (en) Sulfonamide substituted imidazoquinolines
HRP20041152B1 (hr) Farmaceutske formulacije
PL370160A1 (en) Orodispersible pharmaceutical composition comprising agomelatine
IL164217A0 (en) Pharmaceutical compositions containing water-soluble propofol and methods of administering same
EP1419785A4 (en) MEDICAMENTS CONTAINING A CHYMASE INHIBITOR AND ACE INHIBITOR AS ACTIVE INGREDIENTS
IL175210A0 (en) Non-pancreatic proteases and pharmaceutical compositions containing the same
IL169793A (en) Compounds containing antacids and antioxidants and using them for the preparation of a medicinal product
HUP0600778A3 (en) Synthetic human peptides and pharmaceutical compositions comprising them for the treatment of systemic lupus erythematosus
WO2005030142A8 (en) Rifalazil formulations
MY134019A (en) Aryl oxime-piperazines useful as ccr5 antagonists
PL370162A1 (en) Orodispersible pharmaceutical composition comprising perindopril
IL173929A0 (en) Analogues of kahalalide f and pharmaceutical compositions containing the same
IL173626A0 (en) Small peptides and oral pharmaceutical compositions containing the same
ZA200600241B (en) Orodispersible pharmaceutical composition of an antithrombotic compound
AU2003291757A8 (en) Formulations of low solubility bioactive agents and processes for making the same
MXPA03008975A (es) Estabilizacion y esterilizacion terminal de formulaciones de fosfolipidos.
WO2006044548A3 (en) Clopidogrel compositions
GB0201607D0 (en) Formulation for the administration of medicinal substances

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed